Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03930420 · ClinicalTrials.gov registry record · NA

Training LHDs to Disseminate Evidence-Based Interventions to Small Worksites

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
69
Enrollment target

NCT03930420: Completed NA study, sponsored by University of Washington.

NCT03930420 is a NA study that has completed, run by University of Washington. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03930420, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target

Study Summary

The proposed project will advance implementation science by comparing the effectiveness of different levels of technical support in an important but understudied community-based setting: local health departments. The proposed project will also bring Connect to Wellness, an evidence-based approach to disseminating evidence-based interventions and providing implementation support to small worksites, to 40 local health departments and worksites in their communities across the United States. Findings will identify the best approach for national scale-up of Connect to Wellness.

Primary Outcome

The outcome measure is the average number of worksites recruited by the health departments

Interventions

  • BEHAVIORAL Connect to Wellness

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2020-10-01
Est. Completion 2024-03-31
Phase NA
University of Washington

1,048 total trials

What the finished NCT03930420 record still lists

NCT03930420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Connect to Wellness is the first listed.

NCT03930420 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03930420 about?

NCT03930420 is a clinical study titled "Training LHDs to Disseminate Evidence-Based Interventions to Small Worksites". The proposed project will advance implementation science by comparing the effectiveness of different levels of technical support in an important but understudied community-based setting: local health departments. The proposed project will also bring Connect to Wellness, an evidence-based approach to...

What is the current status of trial NCT03930420?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2020-10-01. Estimated completion is 2024-03-31.

What interventions are being tested in trial NCT03930420?

The interventions under investigation include: Connect to Wellness (BEHAVIORAL).

Who is sponsoring clinical trial NCT03930420?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03930420's enrollment target sits among peer trials

69 1133rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03930420, the US trial registry maintained by the National Library of Medicine. NCT03930420 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.